“Anti-PD-1 Immune Checkpoint Blockade-Based Therapy Using Pembrolizumab in a Patient With High-Grade Glioblastoma”. 2023. Biomedical Research and Therapy 10 (5): 5680-85. https://doi.org/10.15419/bmrat.v10i5.809.